Veeva Systems Expands Biotech Footprint with 175+ Emerging Customers…

Event summary

Veeva Systems now serves 175+ emerging biotechs with its Veeva Basics platform, offering pre-configured applications for clinical, regulatory, quality, medical, and commercial operations.
Whitehawk Therapeutics (40 employees) replaced paper processes with Veeva Basics, improving regulatory and quality compliance without an IT team.
Structure Therapeutics insourced submission publishing through Veeva Basics, reducing regulatory timelines and gaining better quality control.
Veeva Basics applications are built on the Vault Platform, designed to scale as biotechs grow from startup to commercialization.

The big picture

Veeva Systems is solidifying its position as the go-to technology provider for emerging biotechs, addressing the need for scalable, compliant solutions in a high-growth sector. The adoption of Veeva Basics reflects a broader industry trend toward digital transformation, where startups prioritize efficiency and regulatory agility to accelerate drug development. With over 1,500 customers, Veeva continues to bridge the gap between large pharmaceutical companies and innovative biotechs, reinforcing its dominance in the life sciences cloud market.

What we're watching

Market Expansion: How Veeva will sustain growth among emerging biotechs as competition in the life sciences cloud space intensifies.
Regulatory Efficiency: Whether the shift from outsourced to insourced regulatory publishing will become an industry standard, driven by Veeva Basics.
Scalability: The pace at which Veeva Basics customers will scale their technology infrastructure as they transition from clinical development to commercialization.